FR940628-2-00045 FR940628-2-00035 FEDERAL TRADE COMMISSION [Dkt. 9251] Synchronal Corporation, et al.; Prohibited Trade Practices and Affirmative Corrective Actions AGENCY: Federal Trade Commission. ACTION: Consent order. SUMMARY: In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent order prohibits, among other things, Thomas L. Fenton, a former officer of Synchronal Corporation, from disseminating a purported baldness cure infomercial, for a product called Omexin; from misrepresenting that any commercial is an independent program; and from making unsubstantiated claims for any food, drug or device in the future. DATES: Complaint issued October 28, 1991. Amended Complaint issued October 6, 1993. Order issued May 13, 1994. 1 1 Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130, 6th Street & Pennsylvania Avenue NW., Washington, DC 20580. FOR FURTHER INFORMATION CONTACT: Lisa Kopchik, FTC/s&hyph;4002, Washington, DC 20580, (202) 326&hyph;3139. SUPPLEMENTARY INFORMATION: On Wednesday, February 23, 1994, there was published in the Federal Register , 59 FR 8645, a proposed consent agreement with analysis In the Matter of Synchronal Corporation, et al., for the purpose of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments, suggestions or objections regarding the proposed form of the order. No comments having been received, the Commission has made its jurisdictional findings and entered an order to cease and desist, as set forth in the proposed consent agreement, in disposition of this proceeding. (Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets or applies sec. 5, 38 Stat. 719, as amended; 15 U.S.C. 45, 52. 39 U.S.C. 3009) Donald S. Clark, Secretary. [FR Doc. 94&hyph;15630 Filed 6&hyph;27&hyph;94; 8:45 am] BILLING CODE 6750&hyph;01&hyph;M
